CorVel Vergangene Ertragsentwicklung

Vergangenheit Kriterienprüfungen 5/6

CorVel verzeichnete einen durchschnittlichen jährlichen Gewinnzuwachs von 12.1%, während die Gewinne der Branche Healthcare jährlich um gewachsen und zwar um 5.6%. Die Umsätze verzeichneten einen durchschnittlichen jährlichen Gewinnzuwachs von gewachsen von 6.7%. Die Eigenkapitalrendite von CorVel beträgt 30.8% und die Nettomargen betragen 9.6%.

Wichtige Informationen

12.1%

Wachstumsrate der Gewinne

14.0%

EPS-Wachstumsrate

Healthcare Wachstum der Industrie	8.5%
Wachstumsrate der Einnahmen	6.7%
Eigenkapitalrendite	30.8%
Netto-Marge	9.6%
Letzte Ertragsaktualisierung	31 Mar 2024

Jüngste Aktualisierungen vergangener Leistungen

Recent updates

We Ran A Stock Scan For Earnings Growth And CorVel (NASDAQ:CRVL) Passed With Ease

Aug 25

CorVel GAAP EPS of $0.94, revenue of $176M

Aug 02

Many Would Be Envious Of CorVel's (NASDAQ:CRVL) Excellent Returns On Capital

Jun 23

Here's Why I Think CorVel (NASDAQ:CRVL) Is An Interesting Stock

May 18

CorVel (NASDAQ:CRVL) Knows How To Allocate Capital

Mar 21

With EPS Growth And More, CorVel (NASDAQ:CRVL) Is Interesting

Feb 14

I Ran A Stock Scan For Earnings Growth And CorVel (NASDAQ:CRVL) Passed With Ease

Nov 16

A Look Into CorVel's (NASDAQ:CRVL) Impressive Returns On Capital

Sep 03

Should You Be Adding CorVel (NASDAQ:CRVL) To Your Watchlist Today?

Aug 16

Aufschlüsselung der Einnahmen und Ausgaben

Wie CorVel Geld verdient und ausgibt. Basierend auf den neuesten gemeldeten Einnahmen der letzten zwölf Monate.

Gewinn- und Umsatzhistorie

NasdaqGS:CRVL Einnahmen, Ausgaben und Erträge (USD Millions)
Datum	Einnahmen	Umsatz	Allgemeine und Verwaltungskosten
31 Mar 24	795	76	77
31 Dec 23	774	75	75
30 Sep 23	751	75	73
30 Jun 23	733	69	71
31 Mar 23	719	66	74
31 Dec 22	704	68	71
30 Sep 22	690	65	71
30 Jun 22	670	66	70
31 Mar 22	646	66	68
31 Dec 21	620	62	67
30 Sep 21	597	59	67
30 Jun 21	576	55	66
31 Mar 21	553	46	64
31 Dec 20	554	43	64
30 Sep 20	561	41	64
30 Jun 20	572	42	65
31 Mar 20	592	47	65
31 Dec 19	596	47	66
30 Sep 19	594	48	65
30 Jun 19	595	48	63
31 Mar 19	596	47	63
31 Dec 18	588	44	62
30 Sep 18	583	43	62
30 Jun 18	571	39	61
31 Mar 18	558	36	59
31 Dec 17	548	35	59
30 Sep 17	536	32	57
30 Jun 17	528	31	58
31 Mar 17	519	29	57
31 Dec 16	513	28	58
30 Sep 16	509	28	58
30 Jun 16	505	29	57
31 Mar 16	504	29	58
31 Dec 15	497	27	56
30 Sep 15	496	28	56
30 Jun 15	495	27	55
31 Mar 15	493	29	54
31 Dec 14	491	31	54
30 Sep 14	489	33	54
30 Jun 14	485	34	53
31 Mar 14	479	34	52
31 Dec 13	471	34	50
30 Sep 13	457	31	49
30 Jun 13	443	29	48

Qualität der Erträge: CRVL hat hohe Qualitätseinkünfte.

Wachsende Gewinnspanne: CRVLDie aktuellen Gewinnspannen (9.6%) sind höher als im letzten Jahr (9.2%).

Analyse von freiem Cashflow und Gewinn

Analyse des Gewinnwachstums in der Vergangenheit

Ergebnisentwicklung: CRVLIn den letzten 5 Jahren sind die Gewinne von 12.1% jährlich gestiegen.

Beschleunigtes Wachstum: CRVLDas Gewinnwachstum des Unternehmens im letzten Jahr (14.9%) übertrifft seinen 5-Jahres-Durchschnitt (12.1% pro Jahr).

Erträge im Vergleich zur Industrie: CRVL Das Gewinnwachstum im vergangenen Jahr (14.9%) übertraf nicht die Entwicklung der Branche Healthcare 15.1% .

Eigenkapitalrendite

Hohe Eigenkapitalrendite: CRVLDie Eigenkapitalrendite des Unternehmens (30.8%) wird als hoch angesehen.

CorVel Vergangene Ertragsentwicklung

Vergangenheit Kriterienprüfungen 5/6

Wichtige Informationen

Jüngste Aktualisierungen vergangener Leistungen

Full year 2024 earnings released: EPS: US$4.45 (vs US$3.83 in FY 2023)

Third quarter 2024 earnings released: EPS: US$1.00 (vs US$0.98 in 3Q 2023)

Second quarter 2024 earnings released: EPS: US$1.16 (vs US$0.84 in 2Q 2023)

First quarter 2024 earnings released: EPS: US$1.16 (vs US$0.95 in 1Q 2023)

Full year 2023 earnings released: EPS: US$3.83 (vs US$3.74 in FY 2022)

Third quarter 2023 earnings released: EPS: US$0.98 (vs US$0.78 in 3Q 2022)

Recent updates

CorVel Corporation, Annual General Meeting, Aug 01, 2024

Independent Director notifies of intention to sell stock

Executive Chairman recently sold US$554k worth of stock

Executive Chairman notifies of intention to sell stock

Full year 2024 earnings released: EPS: US$4.45 (vs US$3.83 in FY 2023)

CorVel (NASDAQ:CRVL) Is Very Good At Capital Allocation

CorVel Corporation's (NASDAQ:CRVL) Share Price Matching Investor Opinion

Is Now The Time To Put CorVel (NASDAQ:CRVL) On Your Watchlist?

Independent Director recently sold US$793k worth of stock

Independent Director notifies of intention to sell stock

President & CEO notifies of intention to sell stock

Independent Director recently sold US$1.2m worth of stock

President & CEO exercised options and sold US$2.0m worth of stock

Executive Chairman recently sold US$719k worth of stock

Executive Chairman notifies of intention to sell stock

Third quarter 2024 earnings released: EPS: US$1.00 (vs US$0.98 in 3Q 2023)

CorVel (NASDAQ:CRVL) Is Very Good At Capital Allocation

The Price Is Right For CorVel Corporation (NASDAQ:CRVL)

With EPS Growth And More, CorVel (NASDAQ:CRVL) Makes An Interesting Case

Executive Chairman recently sold US$1.7m worth of stock

Executive Chairman recently sold US$406k worth of stock

Executive Chairman notifies of intention to sell stock

Second quarter 2024 earnings released: EPS: US$1.16 (vs US$0.84 in 2Q 2023)

CorVel Corporation Announces Promotion of Jeff Gurtcheff to Chief Claims Officer

CorVel (NASDAQ:CRVL) Is Investing Its Capital With Increasing Efficiency

Executive Chairman recently sold US$1.0m worth of stock

CorVel Corporation Announces First Generative AI Module

CorVel Corporation Announces First Generative AI Module

Executive Chairman recently sold US$656k worth of stock

Here's Why We Think CorVel (NASDAQ:CRVL) Is Well Worth Watching

Executive Chairman notifies of intention to sell stock

Executive Chairman recently sold US$860k worth of stock

Executive Chairman notifies of intention to sell stock

First quarter 2024 earnings released: EPS: US$1.16 (vs US$0.95 in 1Q 2023)

We Think CorVel (NASDAQ:CRVL) Might Have The DNA Of A Multi-Bagger

CorVel Corporation, Annual General Meeting, Aug 10, 2023

Chief Information Officer notifies of intention to sell stock

Executive Chairman recently sold US$612k worth of stock

Executive Chairman notifies of intention to sell stock

Full year 2023 earnings released: EPS: US$3.83 (vs US$3.74 in FY 2022)

Chief Financial Officer exercised options and sold US$141k worth of stock

Chief Financial Officer exercised options and sold US$113k worth of stock

CorVel (NASDAQ:CRVL) Is Very Good At Capital Allocation

If EPS Growth Is Important To You, CorVel (NASDAQ:CRVL) Presents An Opportunity

Chief Financial Officer exercised options and sold US$201k worth of stock

Executive Chairman recently sold US$3.3m worth of stock

Vice President of Accounting notifies of intention to sell stock

Third quarter 2023 earnings released: EPS: US$0.98 (vs US$0.78 in 3Q 2022)

President & CEO exercised options and sold US$522k worth of stock

A Look Into CorVel's (NASDAQ:CRVL) Impressive Returns On Capital

Should You Be Adding CorVel (NASDAQ:CRVL) To Your Watchlist Today?

Executive Chairman recently sold US$160k worth of stock

Executive Chairman recently sold US$451k worth of stock

Executive Chairman recently sold US$153k worth of stock

Insufficient new directors

Executive Chairman notifies of intention to sell stock

Executive Chairman recently sold US$236k worth of stock

Second quarter 2023 earnings released: EPS: US$0.84 (vs US$0.90 in 2Q 2022)

CorVel (NASDAQ:CRVL) Looks To Prolong Its Impressive Returns

We Ran A Stock Scan For Earnings Growth And CorVel (NASDAQ:CRVL) Passed With Ease

Lead Independent Director notifies of intention to sell stock

Lead Independent Director notifies of intention to sell stock

Independent Director notifies of intention to sell stock

Executive Chairman recently sold US$166k worth of stock

First quarter 2023 earnings released: EPS: US$0.95 (vs US$0.94 in 1Q 2022)

CorVel GAAP EPS of $0.94, revenue of $176M

Independent Director exercised options to buy US$788k worth of stock.

Lead Independent Director exercised options to buy US$768k worth of stock.

CorVel Corporation, Annual General Meeting, Aug 04, 2022